Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Iron
Drug ID BADD_D01197
Description A metallic element found in certain minerals, in nearly all soils, and in mineral waters. It is an essential constituent of hemoglobin, cytochrome, and other components of respiratory enzyme systems. Its chief functions are in the transport of oxygen to tissue (hemoglobin) and in cellular oxidation mechanisms. Depletion of iron stores may result in iron-deficiency anemia. Iron is used to build up the blood in anemia.
Indications and Usage Used in preventing and treating iron-deficiency anemia.
Marketing Status approved
ATC Code Not Available
DrugBank ID DB01592
KEGG ID Not Available
MeSH ID D007501
PubChem ID 23925
TTD Drug ID D0Y3TM
NDC Product Code 0220-2054; 62106-5042; 68428-383; 64117-791; 0220-2051; 0164-1152
UNII E1UOL152H7
Synonyms Iron | Iron-56 | Iron 56
Chemical Information
Molecular Formula Fe
CAS Registry Number 7439-89-6
SMILES [Fe]
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Ventricular extrasystoles02.03.04.007--Not Available
Ventricular fibrillation02.03.04.008--
Vertigo17.02.12.002; 04.04.01.0030.000453%
Viral infection11.05.04.001--Not Available
Visual impairment06.02.10.0130.000680%Not Available
Vitamin B12 deficiency14.12.02.0040.000453%Not Available
Vomiting07.01.07.0030.003400%
Vulvovaginal dryness21.08.02.0030.000997%
Wheezing22.03.01.009--
Mobility decreased15.03.05.023; 17.02.05.018; 08.01.03.0300.000680%Not Available
Infusion site erythema12.07.05.009; 23.03.06.016; 08.02.05.008--Not Available
Poor venous access24.03.02.017--Not Available
Seasonal allergy22.04.04.008; 10.01.04.001; 06.04.01.013--Not Available
Peripheral swelling08.01.03.053; 02.05.04.0150.000453%Not Available
Emotional distress19.04.02.008--Not Available
General physical health deterioration08.01.03.0180.001360%Not Available
Blood phosphorus decreased13.11.01.015--Not Available
Muscle tightness15.05.03.007--Not Available
Lupus-like syndrome15.06.02.004; 10.04.03.003; 23.03.02.004--Not Available
Skin tightness23.03.03.018--Not Available
Musculoskeletal chest pain22.09.01.001; 15.03.04.012--
Deep vein thrombosis24.01.02.0030.000453%Not Available
Hyperphosphaturia20.02.01.025; 14.04.03.006--Not Available
Injection site discolouration23.03.03.046; 08.02.03.038; 12.07.03.038--Not Available
Large intestine polyp16.05.02.006; 07.20.01.010--Not Available
Acute coronary syndrome24.04.04.011; 02.02.02.015--Not Available
Conjunctival hyperaemia06.04.01.0040.000453%Not Available
Ear discomfort04.03.01.005--Not Available
Ear pruritus04.03.01.011--Not Available
Ocular discomfort06.08.03.008--Not Available
The 11th Page    First    Pre   11 12 13 14    Next   Last    Total 14 Pages